12/21/20 Victorian Cancer Biobank (VCB) profile uploaded

VCB is one of the largest multi-center collection facilities of its kind in the world, collecting tissue and blood from donors at 26 public & private hospitals in metropolitan Melbourne. VCB has an open-door policy to public and private investigators or companies that have an ethically approved research project. It is customer-focused with an archival collection of >400,000 biospecimens in various storage formats and can support prospective collections.

Victorian Cancer Biobank (VCB) (Australia)

Database Contact Data

Wayne Ng, PhD 
General Manager
Victorian Cancer Biobank
615 St. Kilda Rd
Melbourne, Victoria 3004 
AUSTRALIA
Phone: +61 3 9514 6179
Email: Wayne.Ng@cancervic.org.au

Alternate Contact

1. Enquiries
Project Manager
Victorian Cancer Biobank
615 St Kilda Rd
Melbourne, Victoria 3004
AUSTRALIA
Phone 1: +61 3 9514 6186
Phone 2: +61 3 9514 6852
Email: VCBEnquiries@cancervic.org.au

2. If you cannot reach the database manager, you may contact the Biobank by completing the contact form at: https://viccancerbiobank.org.au/services/enquire

References of Studies Using/Describing Database

1. Delahunty RL, Jayawardana M, Arnolda R, Koh TT, Hofman MS, Reid K, Lamont J, Nguyen-Ngo C, Johnston HM, Brooks NG, Wojtowicz P. Perioperative ctDNA as a prognostic biomarker in endometrial cancer-the CODEC study. Translational Oncology. 2026 Sep 1;71:102871.

2. Kuser-Abali G, Noguchi F, Zhao P, Szeto P, Zhang Y, Huang C, Barlow CK, Pomilio G, Boudes M, Chew C, Moghaddam SM. Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP. Molecular Cell. 2026 Jul 2;86(13):2521-38.

3. De Bisscop X, Shewell LK, Day CJ, Jennings MP. Elevation of Serum N-glycolylneuraminic Acid Glycoconjugates in Colorectal Cancer. Biochemical and Biophysical Research Communications. 2026 Feb 20:153500.

4. Marceaux C, Tarasova I, Batey D, Yokote K, Gayevskiy V, Jain R, Leiwe M, Choux L, Riley L, Ribera NT, Yang E, Hywood J, Christie M, Antippa P, Speed TP, Rogers KL, Phipson B, Asselin-Labat ML. TNF-⍺-mediated myeloid-instructed CD14+CD4+ T cells are associated with poor survival in lung adenocarcinoma. Cell Rep Med. 2026 Feb 17;7(2):102593.

5. Cai Z, Boys EL, Noor Z, Aref AT, Xavier D, Lucas N, Williams SG, Koh JM, Poulos RC, Wu Y, Dausmann M. Federated deep learning enables cancer subtyping by proteomics. Cancer Discovery. 2025 Sep 4;15(9):1803-18.

6. Marquina C, Lloyd M, Ng W, Hess J, Evans S, Ademi Z. Evaluating health and well-being returns on investment in a cancer biobank. Biopreservation and Biobanking. 2025 Feb 1;23(1):3-10.

7. Joyce R, Pascual R, Heitink L, Capaldo BD, Vaillant F, Christie M, Tsai M, Surgenor E, Anttila CJ, Rajasekhar P, Jackling FC. Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers. Nature Cell Biology. 2024 Jan 12:1-5.

8. Li R, Liu S, Yeo K, Edwards S, Li MY, Santos R, Kianpour Rad S, Wu F, Maddern G, Young J, Tomita Y. Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease. medRxiv. 2024:2024-03.

9. Tan T, Mouradov D, Lee M, Gard G, Hirokawa Y, Li S, Lin C, Li F, Luo H, Wu K, Palmieri M. Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer. Cell Reports Medicine. 2023 Dec 19;4(12).

10. Lam GT, Sorvina A, Martini C, Prabhakaran S, Ung BS, Lazniewska J, Moore CR, Beck AR, Hopkins AM, Johnson IR, Caruso MC. Altered endosomal-lysosomal biogenesis in melanoma. Neoplasia. 2023 Sep 1;43:100924.

Subscribe to